Ebbah, Dolores .
HRN: 04-05-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CO-AMOXICLAV 625MG (TAB)
11/03/2023
11/06/2023
PO
625mg
Q8
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes